Carolinas HealthCare System

Research and Clinical Trials

Title  
ASPECT
Brief Description  
This study is looking at using Ceftolozane/tazobactam for the treatment of hospital acquired pneumonia. This medication has been approved for use in abdominal infections, however, its use for pneumonia is investigational. It will be compared to meropenem.
Who may be Eligible  
Eligible patients include: Patients are ventilated; proof of infiltrates on radiograph; meet clinical criteria as defined by the protocol; have normal maintenance labs as defined; not be treated with certain antibiotics prior to study; not be immunosuppressed; not have co-morbid conditions as defined by the protocol; contact the study team for details.
Start Date  
02/04/2016
IRB Number  
02-16-02A
Principal Investigator  
Polk, Christopher
Contact Name  
Jessica

For More Information, Contact   Jessica  A.  Kearney-Bryan , BSN
Phone:  (704) 355-0244  Fax:  (l70) 446-7641 
Email:  Jessica.kearney-bryan@carolinashealthcare.org
Address:  1350 S. Kings Drive
Charlotte, NC 28207
Close